FDA Goes Beyond ICH Advice on Dealing with Multiple Endpoints in Clinical Trials

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

FDA Goes Beyond ICH Advice on Dealing with Multiple Endpoints in Clinical Trials

J.W. Schomisch

October 28, 2022 at 03:35 PM EST

The FDA issued final guidance on the analysis, interpretation and management of issues related to the use of multiple endpoints in clinical trials that the agency says “aims to provide greater detail on multiple endpoints beyond what was discussed” in the International Council for Harmonisation (ICH) E9 Statistical Principles for Clinical Trials guidance, which was released ne... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FDA Goes Beyond ICH Advice on Dealing with Multiple Endpoints in Clinical Trials

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT